As per MRFR analysis, the Bio-active Peptide Market Size was estimated at 4.2 (USD Billion) in 2022. The Bio-active Peptide Market is expected to grow from 4.5 (USD Billion) in 2023 to 9.8 (USD Billion) by 2032. The Bio-active Peptide Market CAGR (growth rate) is expected to be around 8.9% during the forecast period (2024 - 2032).
The bioactive peptide Market is driven by rising awareness of the health benefits associated with bioactive peptides, increasing demand for natural and organic food additives, and growing applications in the pharmaceutical industry.
The market is also fueled by the growing adoption of bioactive peptides in functional foods and beverages, as well as the emerging trend of personalized nutrition. Additionally, advancements in biotechnology and genetic engineering techniques have enabled the production of novel bioactive peptides with enhanced functionality.
Opportunities in the bioactive peptide market lie in the untapped potential for applications in the nutraceutical and cosmeceutical industries. The rising demand for personalized health solutions and the growing popularity of bioactive peptides as cosmetic ingredients present significant opportunities for market growth.
Trends in recent times include the development of bioactive peptides with targeted functionalities, such as anti-inflammatory, antioxidant, and antimicrobial properties.
The market is also witnessing a shift towards sustainable and eco-friendly production methods, as well as increased collaborations between academia and industry for research and development.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Rising Prevalence of Chronic Diseases
A significant driver of GBAPMI is the increasing prevalence of chronic diseases such as cardiovascular disease, diabetes, and cancer. These diseases are often associated with inflammation, which can be managed using bioactive peptides.
Bioactive peptides have anti-inflammatory characteristics that may reduce the risk of a person developing these diseases or slow down their progression. For example, Suleria et al. found that bioactive peptides from fish protein hydrolysates have anti-inflammatory activities that could be advantageous in reducing the risk of cardiovascular disease.
The increasing prevalence of chronic diseases is expected to continue, thus increasing the demand for bioactive peptides.
Growing Demand for Functional Foods and Beverages
The Bio-active Peptide Market is majorly being driven by the increased demand for functional foods and beverages. Functional foods and beverages are products that have been fortified with bioactive peptides or other active ingredients that go beyond basic nutrition to provide additional health benefits.
Bioactive peptides can be added to a variety of foods and beverages, such as yogurt, milk, juices, and protein bars. Functional foods and beverages are rapidly growing in popularity around the world as more and more consumers seek ways to improve their health and well-being.
The demand for functional foods and beverages is expected to continue growing in the future, which will increase the demand for bioactive peptides.
Advancements in Biotechnology
The development of new technologies to produce bioactive peptides through advancements in biotechnology has also been noted to be driving the growth of the Bio-Active Bioactive peptides Market. New technologies for producing bioactive peptides have made them easier to produce and more cost-effective.
Technological advancement has also led to the increased discovery of bioactive peptides with new properties. These new bioactive peptides can be applied in several fields, including the treatment of chronic diseases, the manufacture of functional foods and beverages, and the production of cosmetics and personal care products.
The Bio-active Peptide Market is divided on the Type into Synthetic Peptides and Natural Peptides. The Synthetic Peptides segment is expected to dominate the market in 2023 and retain this position until the end of the forecast period.
Thus, the Synthetic Peptides segment is expected to observe rapid growth, as demand continues to rise in the pharmaceutical and biotechnology industries. These are primarily used to develop any type of drug and undertake production procedures. In the long run, synthetic peptides will also be adopted by cosmetics and personal care products.
Alternatively, Plant, animal, and other natural sources are the biological or biotechnological sources used to produce Natural Peptides by this standard. The use of natural peptides in the nutraceutical and specialty foods sectors is becoming more widespread due to how they aid in improving the immune system, digestion, and cognitive function of the human body.
During the forecast timeframe, the Natural Peptides Market is expected to increase at a steady rate. Revenue for the bioactive peptides market is anticipated to increase in the coming years.
The Bio Characteristic Peptide Market is anticipated to grow rapidly, reaching USD 52.5 billion by 2032.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Bio-active Peptide Market is segmented by source into plants, animals, and microorganisms. The plant segment is accounted to hold the highest market share due to the increasing demand for plant-based bioactive peptides in the food and beverage industry.
The animal segment is expected to witness significant growth due to the rising consumption of meat and poultry products. The microorganisms segment is anticipated to grow steadily over the forecast period owing to the increasing use of microorganisms in the production of bioactive peptides for pharmaceutical and industrial applications.
In 2023, the Bio-active Peptide Market revenue was valued at USD 24.73 Billion. The growth of the market is attributed to the increasing demand for bioactive peptides in the food and beverage, pharmaceutical, and cosmetic industries.
The Bio-active Peptide Market segmentation by function offers insights into the diverse applications of bioactive peptides in various industries. Antimicrobial peptides, with a market revenue of USD 1.56 billion in 2023, are gaining prominence in the healthcare sector due to their ability to combat microbial infections.
Anti-inflammatory peptides, valued at USD 0.98 billion in 2023, hold significant potential in treating chronic inflammatory diseases. Antioxidant peptides, boasting a market size of USD 0.72 billion in 2023, are increasingly used in skincare and nutraceutical products.
Neuroprotective peptides, with a market valuation of USD 0.63 billion in 2023, are gaining traction in the pharmaceutical industry for their therapeutic benefits in neurodegenerative disorders. Immunomodulatory peptides, valued at USD 0.59 billion in 2023, play a crucial role in regulating immune responses and are being explored for immunotherapies.
This market segmentation provides valuable insights for industry participants to tailor their strategies and capitalize on the growth potential of each function within the Bio-active Peptide Market.
The Bio-active Peptide Market segmentation by Application includes Pharmaceuticals, Nutraceuticals, Cosmetics, and Agriculture. The Pharmaceuticals segment held the largest market share in 2023, accounting for over 45% of the Bio-active Peptide Market revenue.
This segment is expected to continue to dominate the market throughout the forecast period, driven by the increasing demand for Bio-active Peptides in drug development and manufacturing. The Nutraceuticals segment is expected to witness significant growth during the forecast period, owing to the rising popularity of natural and organic supplements.
The Cosmetics segment is also expected to grow steadily as bioactive peptides gain traction in anti-aging and skin care products. The agriculture segment is expected to experience moderate growth as bioactive peptides are increasingly used as crop protection agents and fertilizers.
The Bio-active Peptide Market segmentation by region includes North America, Europe, APAC, South America, and MEA.
North America is the largest market for Bio-active Peptides, driven by the growing demand for nutraceuticals and functional foods.
Europe is the second largest market, followed by APAC. The APAC region is expected to witness the fastest growth over the forecast period due to rising disposable income and increasing awareness about the health benefits of Bio-active Peptides.
South America and MEA are expected to grow at a steady pace over the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Bio-active Peptide Market Key Players and Competitive Insights:
Major players in the Bio-active Peptide Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and forming strategic partnerships.
Leading Bio-active Peptide Market players are focusing on developing innovative products to meet the evolving needs of customers. Bio-active Peptide Market development is driven by factors such as rising demand for functional foods, increasing awareness of the health benefits of bioactive peptides, and advancements in biotechnology.
The competitive landscape of Bio-active Peptide Market is expected to remain highly competitive, with key players vying for market share through product differentiation, pricing strategies, and distribution channels.
Azelis, a leading specialty chemicals distributor, has a strong presence in the Bio-active Peptide Market. The company offers a wide range of bioactive peptides from various suppliers, enabling it to meet the diverse needs of its customers.
Azelis has a network of technical experts who provide support and guidance to customers in selecting the right peptides for their specific applications. The company's commitment to quality and customer satisfaction has made it a trusted partner for many businesses in the Bio-active Peptide Market.
Another major player in the Bio-active Peptide Market is Peptide International, a leading manufacturer of high-quality bioactive peptides. The company has a state-of-the-art manufacturing facility that produces peptides using advanced technologies.
Peptide International offers a wide range of peptides, including custom peptides, GMP peptides, and research peptides. The company's products are used in various applications, including pharmaceuticals, cosmetics, and dietary supplements. Peptide International's focus on innovation and quality has made it a preferred supplier for many businesses in the Bio-active Peptide Market.
Key Companies in the Bio-active Peptide Market Include:
Bio-active Peptide Market Developments
Rising demand for bioactive peptides in pharmaceuticals and nutraceuticals, coupled with increasing consumer awareness about health and wellness, drives market growth. Technological advancements, such as the development of novel peptide synthesis techniques, further contribute to market expansion.
Key players are focusing on strategic collaborations and acquisitions to strengthen their market position and expand their product offerings. Recent developments include the acquisition of Antares Pharma by Halozyme Therapeutics for $960 million, enhancing Halozyme's portfolio of peptide-based drug delivery technologies.
| Report Attribute/Metric | Details |
| Market Size 2022 | 4.2 (USD Billion) |
| Market Size 2023 | 4.5 (USD Billion) |
| Market Size 2032 | 9.8(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 8.9% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | California Peptide Research, GeneCust, New England Peptide LLC, GenScript, NeoBioScience Technology, CPC Scientific, JPT Peptide Technologies, Peptide International, SynPeptide Technologies, BioSynthesis, Anaspec, Bachem, PolyPeptide Group, Peptron, LifeTein |
| Segments Covered | Type, Source, Function, Application, Regional |
| Key Market Opportunities | Therapeutic Potential in Cardiovascular Diseases Growing Personalized Nutrition Trends Advancements in Bioengineering Expansion in Cosmetic and Personal Care Emerging Applications in Agriculture |
| Key Market Dynamics | Rising prevalence of chronic diseases Growing demand for natural and functional food ingredients Technological advancements in peptide synthesis Increasing research and development activities Growing awareness of the health benefits of bioactive peptides |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Bio-active Peptide Market is expected to reach a valuation of USD 4.5 billion in 2023 and is projected to register a CAGR of 8.9%, reaching USD 9.8 billion by 2032.
North America is expected to hold the largest market share in the Bio-active Peptide Market, followed by Europe and Asia-Pacific. The growth in these regions can be attributed to rising demand for functional food and beverages, increasing prevalence of chronic diseases, and growing awareness about the health benefits of bioactive peptides.
The functional food and beverages segment is expected to hold the largest market share in the Bio-active Peptide Market, followed by the dietary supplements segment. The growth in these segments can be attributed to the increasing demand for food and beverages that offer health benefits beyond basic nutrition.
Some of the key competitors in the bioactive peptide Market include Rousselot, Royal DSM, FrieslandCampina, Glanbia, and Bio-Techne. These companies are investing in research and development to expand their product offerings and strengthen their market positions.
The growth of the bioactive peptide Market is primarily driven by increasing consumer awareness about the health benefits of bioactive peptides, rising demand for functional food and beverages, and the growing prevalence of chronic diseases. Additionally, government regulations supporting the use of bioactive peptides in food and beverages are further contributing to the market growth.
The bioactive peptide Market faces challenges such as the high cost of production, regulatory hurdles, and the need for extensive research to demonstrate the efficacy and safety of bioactive peptides. Additionally, the market is characterized by intense competition, which can make it difficult for new entrants to gain market share.
The latest trends in the bioactive peptide Market include the growing use of bioactive peptides in personalized nutrition, the development of novel delivery systems for bioactive peptides, and the increasing adoption of bioactive peptides in the cosmetics and personal care industry.
The Bio-active Peptide Market has significant growth opportunities in emerging markets, the development of new applications for bioactive peptides, and the increasing demand for natural and organic food and beverages.
The COVID-19 pandemic had a positive impact on the Bio-active Peptide Market as consumers became more health-conscious and sought out products that could support their immune systems. The demand for bioactive peptides increased as they were found to have antiviral and anti-inflammatory properties.
The regulatory landscape for the Bio-active Peptide Market varies by region. In the United States, bioactive peptides are regulated as food ingredients by the Food and Drug Administration (FDA). In the European Union, bioactive peptides are regulated as novel foods by the European Food Safety Authority (EFSA).
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
